**Question:** Which of the following is not used in glaucoma in a hypertensive patient?

A. Timolol
B. Latanoprost
C. Brimonidine
D. Aprepitant

**Core Concept**

Glaucoma is a group of eye disorders characterized by increased intraocular pressure (IOP) leading to optic nerve damage and potential vision loss. Hypertension, or high blood pressure, is a systemic condition that can negatively impact ocular blood flow and contribute to the development or progression of glaucoma. Treatment options for glaucoma typically aim to lower intraocular pressure and improve ocular perfusion.

**Why the Correct Answer is Right**

Aprepitant is a drug primarily used for the prevention of chemotherapy-induced nausea and vomiting. It belongs to the class of drugs known as neurokinin 1 receptor antagonists. In contrast, the other three options are medications used specifically for glaucoma management:

A. Timolol: A nonselective beta-blocker that decreases aqueous humor production and reduces intraocular pressure.
B. Latanoprost: A prostaglandin F2α analog that increases outflow of aqueous humor, reducing intraocular pressure.
C. Brimonidine: A selective alpha-2 adrenergic agonist that reduces intraocular pressure through both increased outflow and reduced production.

**Why Each Wrong Option is Incorrect**

D. Aprepitant is not used for glaucoma as it is a medication primarily targeting nausea and vomiting, not intraocular pressure regulation.

E. Timolol is a beta-blocker that can potentially worsen hypertension by causing peripheral vasoconstriction and reducing cardiac output.
F. Latanoprost is a prostaglandin, which can be associated with some systemic side effects like ocular hyperemia, conjunctival hyperemia, and headache. However, these side effects are generally mild and well-tolerated.
G. Brimonidine has some systemic side effects like bradycardia, hypotension, and fatigue, which can worsen hypertension. Additionally, its use in glaucoma treatment is limited, as it is a selective alpha-2 agonist, which may not have significant effects in hypertensive patients.

**Clinical Pearl**

In managing hypertension, it is essential to consider the potential interactions between medications used for systemic hypertension treatment and glaucoma medications. Hypertensive patients should generally avoid beta-blockers like Timolol, and alpha-2 agonists like Brimonidine due to potential worsening of hypertension and increased systemic side effects.

In contrast, prostaglandin analogs like Latanoprost are generally well-tolerated and effective in lowering intraocular pressure, making them a more suitable choice for glaucoma patients with hypertension.

**Why the Correct Answer is Right**

Aprepitant is not used for glaucoma management as it is primarily designed for antiemetic therapy. The other three options, however, are commonly used medications for glaucoma treatment:

1. Timolol (Beta-blocker)